Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026)
Nuwellis' (NUWE) quarterly Other Non-Current Liabilities came in at $7.0 million in Q2 2026, down 50.53% on a YoY basis from $14.1 million in Q2 2025, and up 1823.48% quarter-over-quarter from $362000.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Other Non-Current Liabilities for 10 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 50.53% year-over-year to $7.0 million; the trailing twelve-month figure through Jun 2026 stood at $7.0 million (down 50.53% YoY), and the FY2025 full-year result was $389000.0, down 16.88% from the prior year.
- Other Non-Current Liabilities advanced to $7.0 million in Q2 2026 per NUWE's latest filing, from $362000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $14.1 million in Q2 2025 and bottomed at $71000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $3.3 million across 5 years, with a median of $480000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 3736.87% in 2022, then sank 83.54% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $6.9 million in 2022, then plunged by 58.61% to $2.8 million in 2023, then tumbled by 83.54% to $468000.0 in 2024, then slipped by 16.88% to $389000.0 in 2025, then soared by 1689.97% to $7.0 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $7.0 million, $362000.0, and $389000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.96 Mn |
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | 389,000.00 |
| Sep 30, 2025 | 420,000.00 |
| Jun 30, 2025 | 14.07 Mn |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 8.58 Mn |
| Mar 31, 2024 | 964,000.00 |
| Dec 31, 2023 | 2.84 Mn |
| Dec 31, 2022 | 6.87 Mn |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | 286,000.00 |
| Sep 30, 2018 | 126,000.00 |
| Jun 30, 2018 | 126,000.00 |
| Mar 31, 2018 | 126,000.00 |
| Dec 31, 2017 | 126,000.00 |
| Sep 30, 2017 | 126,000.00 |